{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T03:52:46Z","timestamp":1703130766253},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.disamonth.2006.10.008","type":"journal-article","created":{"date-parts":[[2007,1,14]],"date-time":"2007-01-14T07:07:09Z","timestamp":1168758429000},"page":"59-63","source":"Crossref","is-referenced-by-count":1,"title":["New Drugs and Vaccines"],"prefix":"10.1016","volume":"53","author":[{"given":"Henry","family":"Yeager","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.disamonth.2006.10.008_bib1","unstructured":"No author listed. The Global Plan to Stop TB. 2006-2015 (press announcement, January 27, 2006. Davos, Switzerland). Available at: www.who.int\/tb\/features_archive\/global_plan_to_stop_tb\/en\/."},{"key":"10.1016\/j.disamonth.2006.10.008_bib2","series-title":"Reichman and Hershfield\u2019s Tuberculosis, A Comprehensive, International Approach","author":"Raviglione","year":"2006"},{"key":"10.1016\/j.disamonth.2006.10.008_bib3","series-title":"Reichman and Hershfield\u2019s Tuberculosis, A Comprehensive International Approach","first-page":"1135","article-title":"New drugs for tuberculosis","author":"Ginsberg","year":"2006"},{"key":"10.1016\/j.disamonth.2006.10.008_bib4","first-page":"603","article-title":"Treatment of tuberculosis","volume":"67","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.disamonth.2006.10.008_bib5","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1001\/jama.293.22.2776","article-title":"Update on the treatment of tuberculosis and latent tuberculosis infection","volume":"293","author":"Blumberg","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.disamonth.2006.10.008_bib6","unstructured":"No author listed. Antibiotic gatifloxacin (Tequin) removed from market. http:\/\/www.mayoclinic.con\/health\/tequin\/D100058."},{"key":"10.1016\/j.disamonth.2006.10.008_bib7","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1164\/rccm.200305-682OC","article-title":"The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis","volume":"168","author":"Gosling","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 3","key":"10.1016\/j.disamonth.2006.10.008_bib8","first-page":"1","article-title":"A strategic plan for the elimination of tuberculosis in the Unites States","volume":"38","year":"1989","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.disamonth.2006.10.008_bib9","series-title":"Reichman and Hershfield\u2019s Tuberculosis, A Comprehensive International Approach","first-page":"1153","article-title":"The future of tuberculosis vaccinology","author":"Griffin","year":"2006"},{"key":"10.1016\/j.disamonth.2006.10.008_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(06)68389-X","article-title":"Progress and hindrances in tuberculosis vaccine development","volume":"367","author":"Doherty","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.disamonth.2006.10.008_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vaccine.2005.07.078","article-title":"Preclinical testing of new vaccines for tuberculosis","volume":"24","author":"Orme","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.disamonth.2006.10.008_bib12","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study","volume":"291","author":"Aronson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.disamonth.2006.10.008_bib13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/01.mcp.0000219267.27439.1b","article-title":"Tuberculosis vaccines: past present and future","volume":"112","author":"Martin","year":"2006","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.disamonth.2006.10.008_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tube.2004.09.015","article-title":"Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials","volume":"85","author":"McShane","year":"2005","journal-title":"Tuberculosis"},{"key":"10.1016\/j.disamonth.2006.10.008_bib15","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.micinf.2005.04.002","article-title":"Recombinant BCG expressing Mycobacterium tuberculosis major extracellular proteins","volume":"7","author":"Horwitz","year":"2005","journal-title":"Microbes Infect"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502906001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502906001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T20:22:35Z","timestamp":1547065355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502906001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0011502906001106"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2006.10.008","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}